{
  "patient_information": "A 30-year-old male Chinese itinerant trader with no other reported comorbidities.",
  "chief_complaint": "A 7-day history of fever, chills, headache and a dry cough.",
  "history_of_present_illness": "The patient developed slide-positive falciparum malaria while living in southern Laos and self-treated with intravenous and intramuscular artemether 80 mg for 5 days, using medication he brought from China. He did not improve; the fever persisted, he developed jaundice, and was subsequently transferred to a hospital in Vientiane for further management.",
  "exposure_and_epidemiology": "The patient was an itinerant trader living in southern Laos, a region endemic for falciparum malaria, including artemisinin-resistant strains, as well as other infections like scrub typhus, murine typhus, and leptospirosis. His exposure was to a substandard antimalarial drug he had brought from China.",
  "vitals": "On admission to the hospital in Vientiane, he was febrile with a temperature of 39.5°C (103.1°F). His blood pressure and Glasgow Coma Score were reported as normal.",
  "physical_exam": "Clinical findings on admission included nausea, dry cough, moderate dehydration, chest pain, and abdominal tenderness. His chest was clear on auscultation, and no hepatosplenomegaly was detected.",
  "labs_and_diagnostics": "On admission, a Giemsa smear was negative for malaria parasites, but a rapid diagnostic test (HRP-2) was positive for Plasmodium falciparum. Serum creatinine and glucose were normal. Liver function tests were elevated with an ALT of 301 U/L, AST of 230 U/L, and ALP of 470 U/L. Total bilirubin was 14 µmol/L and direct bilirubin was 6.4 µmol/L. Subsequent analysis of the artemether he had used showed it was substandard, containing only 59 mg, which was 74% of the stated dose.",
  "differential_diagnosis": "The differential diagnoses considered for the persistent fever included bacterial co-infection (especially Salmonella), another common infectious disease from Laos (such as scrub typhus, murine typhus, leptospirosis, or dengue fever), or failure of malaria treatment. Potential causes for treatment failure included artemisinin-resistant falciparum malaria, incorrect dosing, or the use of a poor-quality antimalarial drug.",
  "management_and_clinical_course": "After failing to improve on a 5-day course of self-administered artemether, the patient was treated with oral quinine sulphate 10 mg/kg every 8 hours and doxycycline 100 mg every 12 hours for a duration of 7 days. His fever resolved 35 hours after starting this new therapy, and he was discharged well. Investigations found no evidence of any other infections.",
  "final_diagnosis": "The final diagnosis was treatment failure of falciparum malaria due to the use of a substandard medication. The initial malaria infection was confirmed by a positive HRP-2 test, despite a negative smear post-treatment. The failure to respond to the initial 5-day course of artemether was determined to be caused by the poor quality of the drug, which chemical analysis revealed was significantly underdosed (74% of stated content). The patient's rapid clinical resolution with a standard course of quality-assured quinine and doxycycline supported this conclusion over drug resistance or a co-infection.",
  "disease_name_short": "Falciparum malaria"
}